Roche and Isis Pharmaceuticals Form Alliance for Huntington's Disease

News   Apr 10, 2013

 
Roche and Isis Pharmaceuticals Form Alliance for Huntington's Disease
 
 
 

RELATED ARTICLES

Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut Flora

News

An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.

READ MORE

A Mechanism of Drug Resistance in Breast & Ovarian Cancer

News

Researchers have discovered the molecular means by which some cancers caused by errors in the gene BRCA1 evade treatment by drugs custom-tailored to kill them.

READ MORE

Modified Form of Botox Could Replace Opioids as Treatment for Chronic Pain

News

A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy